共 50 条
- [2] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
- [5] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer [J]. Medical Oncology, 2008, 25 : 303 - 308